Last updated: 13.02.2014

Address: 2, ul. Chermyanskaya, 127282 Moscow,Russia

Tel: + 7 (495) 730-78-28


Company description

Protek Group is one of one of the lagest pharmaceutical company in Russia*. The Group has diversified business interests and is active in all major segments of the pharmaceutical industry such as manufacture of medicinal products, wholesaling and retailing of pharmaceuticals, beauty and health products. The Group employs more than 12 thousand people.

The Group is vertically integrated, which enables it to set up a complete product supply chain from Production to Wholesale to Retail sales. The Group’s key assets: CV Protek, a national distributor of pharmaceuticals, beauty and health products; Sotex, a manufacturer of medical products; and Rigla pharmacy chain. In 2002, as part of the Group’s restructuring, OAO Protek was set up as the Group’s parent company to consolidate the equity interests (shares) in its subsidiaries and associates.

CV Protek is a major distributor of pharmaceuticals, beauty and health products in Russia. It has been active in Russia’s pharmaceutical market since 1990. Based on it’s 2010 performance, CV Protek takes first place in overall ranking of pharmaceutical distributors**. The company supplies medicines to all 83 constituent territories of the RF; its total warehouse space, according to 2010 figures, is near 159,000 sq.m.

Rigla pharmacy chain comes second in the ranking of major pharmacy chains in Russia in terms of sales**. The chain boasts 655*** pharmacies in 26 regions of Russia and Ukraine.

The Production segment is based on Sotex company. The company’s manufacturing facility, located in the Sergiyev-Posad district of the Moscow region, makes ampoule injection solutions of liquid INPN generics, patented-content medicines and its own-brand medicines. The facility is one of the most advanced high-tech pharmaceutical manufacturers in Russia.

Protek Group embraces state-of-the-art standards in financial management. Its core elements are as follows: corporate financial reporting in compliance with the International Accounting Standards (IAS), international audit, sound financial policies, and Oracle E-Business Suite-based enterprise resource planning in segments.

The Group’s business practices aim to improve the competitiveness and resilience of the Group’s business as a whole, and to maximize the market cap of each company in its segment.

The Group is active in a socially significant sector and is committed to socially responsible business practices, fully honouring its obligations to its partners, staff and society. The Group provides sponsorship and charitable donations for cultural, historical and research projects, as well as humanitarian assistance.

Protek Group’s mission: Our mission is to care for human beauty and health. We put a premium on the economic, social and ethical values of society, honour our commitments to the public, partners and the government, thus setting business standards.

* In terms of sales

**Source: DSM Group
*** Company data on 31.06.2011

Products and services

Vertically integrated pharmaceutical comany operating in production, distribution/wholesale, and retail



We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here